(2-Fluoro-3-methylpyridine-5-yl)boronic acid, 95.0%, 100g

5-(3-Aminophenyl)oxazole, 95.0%, 10g

2,2-Diethoxypropane, 25g

3,5-Dibromo-2-ethyl-6-iodobenzoic acid, 100g

[2-(1-methyl-1H-benzimidazol-2-yl)ethyl]amine dihydrochloride, 95.0%, 1g

Phase contrast slide set with 20x and S100x PLPHi IOS infinity corrected objectives and phase contrast rings for 20x/S100x

2,6-Dibromo-4-chloropyridine, 95.0%, 100g

(S)-2-Amino-3-(5-iodo-2-methylphenyl)propanoic acid, 95%, 1g

2-(2,2-DIFLUOROETHOXY)NICOTINIC ACID, 95.0%, 250mg

Methyl 4-amino-3-bromobenzoate, 95.0%, 5g

1,3,5-Tris[4-(chloromethyl)phenyl]benzene, 98%, 100mg

tert-butyl 4-bromo-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate, 95.0%, 10g

N-Carbamoyl-2-cyanoacetamide, 95.0%, 250g